RYZODEG^®
(insulin aspart, insulin degludec)
NOVO NORDISK
HK Reg. No. HK-68663 (28 Apr, 2025) 
Composition:⁴

• Ryzodeg 100 units/mL FlexTouch solution for injection in pre-filled pen
• 1 mL solution contains 100 units insulin degludec/insulin aspart in the ratio 70/30 (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart)

• One pre-filled pen contains 300 units of insulin degludec/insulin aspart in 3 mL solution

Indication:⁴

• Treatment of diabetes mellitus in adults, adolescents and children from the age of 2 years

References

4. EMA. Summary of Product Characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/ryzodeg-epar-product-information_en.pdf. [Accessed 16 May 2025].